Use of aromatase inhibitors and risk of cardiovascular disease: A population-based study.

被引：0
|
作者：
McVicker, Lauren [1 ]
Cardwell, Christopher [1 ]
McMenamin, Una [1 ]
机构：
[1] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-077
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
    Sund, Maria
    Garcia-Argibay, Miguel
    Garmo, Hans
    Ahlgren, Johan
    Wennstig, Anna-Karin
    Fredriksson, Irma
    Lindman, Henrik
    Valachis, Antonis
    BREAST, 2021, 59 : 157 - 164
  • [2] Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer A Population-Based Cohort Study
    Khosrow-Khavar, Farzin
    Filion, Kristian B.
    Bouganim, Nathaniel
    Suissa, Samy
    Azoulay, Laurent
    CIRCULATION, 2020, 141 (07) : 549 - 559
  • [3] Patterns of use of tamoxifen and aromatase inhibitors: A population-based observational study
    Huiart, L.
    Dell'Aniello, S.
    Suissa, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study
    Khosrow-Khavar, Farzin
    Azoulay, Laurent
    Montastruc, Jean-Louis
    Montastruc, Francois
    Renoux, Christel
    CANCER, 2022, 128 (12) : 2339 - 2347
  • [5] Bronchiectasis and the risk of cardiovascular disease: a population-based study
    Navaratnam, Vidya
    Millett, Elizabeth R. C.
    Hurst, John R.
    Thomas, Sara L.
    Smeeth, Liam
    Hubbard, Richard B.
    Brown, Jeremy
    Quint, Jennifer K.
    THORAX, 2017, 72 (02) : 161 - 166
  • [6] Aromatase inhibitors and the incidence of Parkinson's disease: Population-based cohort study
    Montastruc, Fran Ois
    Khosrow-Khavar, Farzin
    Azoulay, Laurent
    Montrastruc, Jean-Louis
    Renoux, Christel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 277 - 278
  • [7] Dyslipidemic hypertension: features and cardiovascular risk in a prospective population-based study.
    Onat, A
    Hergenc, G
    Sary, I
    Turkmen, S
    Can, G
    Sansoy, V
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 : 86 - 86
  • [8] The Risk of Cardiovascular Disease in Postmenopausal Oestrogen Receptor-Positive Breast Cancer Patients Treated with Aromatase Inhibitors: A UK Population-based Study
    McVicker, Lauren
    Cardwell, Christopher
    Hicks, Blanaid
    Pottegard, Anton
    McMenamin, Una
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 84 - 85
  • [9] Hysterectomy and risk of cardiovascular disease: a population-based cohort study
    Ingelsson, Erik
    Lundholm, Cecilia
    Johansson, Anna L. V.
    Altman, Daniel
    EUROPEAN HEART JOURNAL, 2011, 32 (06) : 745 - 750
  • [10] Risk and predictors of cardiovascular disease in psoriasis: a population-based study
    Maradit-Kremers, Hilal
    Dierkhising, Ross A.
    Crowson, Cynthia S.
    Icen, Murat
    Ernste, Floranne C.
    McEvoy, Marian T.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (01) : 32 - 40
12345